Capstone Therapeutics Corp.
Records under this name other than patents Capstone Therapeutics Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Capstone Therapeutics Corp.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,334,259 | Method of Treating Endothelial Dysfunction Comprising Administration of a Thrombin Peptide Derivative Formerly held In force · High confidence | In force | High confidence | |
| US 8,952,129 | Method of treating degenerative diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,833,982 | Methods of Treating Dermal Ulcers with Thrombin Derived Peptides Formerly held Term ended Ended no later than Jul 18, 2022 · Low confidence | Term ended | Ended no later than Jul 18, 2022 | Low confidence |
| US 6,867,190 | Methods of Therapy with Thrombin Derived Peptides Formerly held Term ended Ended no later than Jun 29, 2022 · Medium confidence | Term ended | Ended no later than Jun 29, 2022 | Medium confidence |
| US 7,049,294 | Use of Thrombin-Derived Peptides for the Therapy of Chronic Dermal Ulcers Formerly held Term ended Term ended Jan 16, 2022 · High confidence | Term ended | Term ended Jan 16, 2022 | High confidence |
| US 7,378,500 | Use of thrombin-derived peptides for the therapy of chronic dermal ulcers Formerly held Term ended Ended no later than Jan 16, 2022 · From the USPTO record | Term ended | Ended no later than Jan 16, 2022 | From the USPTO record |
| US 6,914,050 | Stimulation of Bone Growth with Thrombin Peptide Derivatives Formerly held Term ended Term ended Sep 29, 2021 · High confidence | Term ended | Term ended Sep 29, 2021 | High confidence |
| US 6,894,027 | Stimulation of Bone Growth with Thrombin Peptide Derivatives Formerly held Lapsed on the fee record Ended May 17, 2017 · High confidence | Lapsed on the fee record | Ended May 17, 2017 | High confidence |
| US 6,855,687 | Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor Formerly held Lapsed on the fee record Ended Feb 15, 2017 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2017 | From the USPTO record |
| US 6,815,416 | Stimulation of Cartilage Growth with Agonists of the Non-Proteolytically Activated Thrombin Receptor Formerly held Lapsed on the fee record Ended Nov 9, 2016 · Medium confidence | Lapsed on the fee record | Ended Nov 9, 2016 | Medium confidence |